Veracyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. 

CEO
Marc A. Stapley
CEOMarc A. Stapley
Employees
824
Employees824
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2006
Founded2006
Employees
824
Employees824

VCYT Key Statistics

Market cap
2.10B
Market cap2.10B
Price-Earnings ratio
63.93
Price-Earnings ratio63.93
Dividend yield
Dividend yield
Average volume
884.82K
Average volume884.82K
High today
$27.11
High today$27.11
Low today
$25.99
Low today$25.99
Open price
$26.69
Open price$26.69
Volume
675.30K
Volume675.30K
52 Week high
$47.32
52 Week high$47.32
52 Week low
$19.73
52 Week low$19.73

VCYT News

Simply Wall St 5d
Veracyte, Inc.'s Shares Lagging The Industry But So Is The Business

You may think that with a price-to-sales (or "P/S") ratio of 4.5x Veracyte, Inc. ( ) is a stock worth checking out, seeing as almost half of all the Biotechs co...

Veracyte, Inc.'s Shares Lagging The Industry But So Is The Business

Analyst ratings

83%

of 12 ratings
Buy
83.3%
Hold
8.3%
Sell
8.3%

People also own

Based on the portfolios of people who own VCYT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.